Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7808ce6471be5db8d3dbdbb89076e52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d84d92eec9f232ace0dcb0df59c22c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7349ea237e4e4d66531f15303061a081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_315b61b9bcece11006c1b8c397d87781 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ed048649575f6f06743e179e6842580 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1161ee5550ddfe2394600f0c32b30d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51d28aa4535a45f54291d08880ad2a02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73787444caaa9deb20b0426832cd037f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a13882fa4e6f6648eb052ba86e2cbd36 |
publicationDate |
2015-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9127061-B2 |
titleOfInvention |
Anti-human P-cadherin (CDH3) recombinant antibody |
abstract |
It is an object to provide a recombinant antibody that is an anti-CDH3 antibody having cytotoxicity on CDH3-expressing cells, which is anticipated to have fewer side effects than antibodies derived from animals other than humans and to maintain its therapeutic effects for a long period of time. The present invention provides a recombinant antibody which specifically reacts with an epitope existing in the amino acids at positions 108 to 131 or at positions 551 to 654 of the amino acid sequence shown in SEQ ID NO: 38 that is the extracellular region of human CDH3, and has cytotoxicity against CDH3-expressing cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723971-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884921-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537633-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020060781-A1 |
priorityDate |
2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |